Items

• Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes (2020-10)

  CP. Cannon, R. Pratley, S. Dagogo-Jack, J. Mancuso, S. Huyck, U. Masiukiewicz, B. Charbonnel, R. Frederich, S. Gallo, F. Cosentino, WJ Shih, I. Gantz, SG. Terra, DZI. Cherney, DK. McGuire, V. Soldat-Stanković, Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes, NEW ENGLAND JOURNAL OF MEDICINE, Vol. 383, No. 15, pp. 1425 - 1435, Oct, 2020

• Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial (2021-09)

  DZI. Cherney, F. Cosentino, S. Dagogo-Jack, DK. McGuire, R. Pratley, R. Frederich, M. Maldonado, CC. Liu, J. Liu, A. Pong, CP. Cannon, V. Soldat-Stanković, Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, Vol. 16, No. 9, pp. 1345 - 1354, Sep, 2021